GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » Additional Paid-In Capital

iZafe Group AB (OSTO:IZAFE B) Additional Paid-In Capital : kr130.54 Mil(As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB Additional Paid-In Capital?


iZafe Group AB's quarterly additional paid-in capital stayed the same from Sep. 2024 (kr130.87 Mil) to Dec. 2024 (kr130.87 Mil) and stayed the same from Dec. 2024 (kr130.87 Mil) to Mar. 2025 (kr130.54 Mil).

iZafe Group AB's annual additional paid-in capital declined from Dec. 2022 (kr131.78 Mil) to Dec. 2023 (kr130.98 Mil) and declined from Dec. 2023 (kr130.98 Mil) to Dec. 2024 (kr130.87 Mil).

iZafe Group AB Additional Paid-In Capital Historical Data

The historical data trend for iZafe Group AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iZafe Group AB Additional Paid-In Capital Chart

iZafe Group AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.15 69.91 131.78 130.98 130.87

iZafe Group AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 131.07 130.87 130.87 130.87 130.54

iZafe Group AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

iZafe Group AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

iZafe Group AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » Additional Paid-In Capital
Comparable Companies
OSTO:ORTI A XSAT:ODIN XSAT:SERV OSTO:S2M XSAT:AUDNTS NGM:PRLD ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 XPAR:DIM OCSE:COLO B XSWX:STMN XTER:SRT WST BAX HOLX
Traded in Other Exchanges
M02:Germany
Address
David Bagares Gata 3, Stockholm, SWE, 111 38
Website
https://www.izafe.se
iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB Headlines

No Headlines